These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37823884)

  • 1. [Influenza vaccination as secondary prevention for cardiovascular disease].
    Vollaard AM; Slok ENE; van Dijkman PRM; Dekkers OM; Groeneveld GH
    Ned Tijdschr Geneeskd; 2023 Oct; 167():. PubMed ID: 37823884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis.
    Maniar YM; Al-Abdouh A; Michos ED
    Curr Cardiol Rep; 2022 Oct; 24(10):1327-1335. PubMed ID: 35876953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial.
    Loeb M; Roy A; Dokainish H; Dans A; Palileo-Villanueva LM; Karaye K; Zhu J; Liang Y; Goma F; Damasceno A; Alhabib KF; Yonga G; Mondo C; Almahmeed W; Al Mulla A; Thanabalan V; Rao-Melacini P; Grinvalds A; McCready T; Bangdiwala SI; Yusuf S;
    Lancet Glob Health; 2022 Dec; 10(12):e1835-e1844. PubMed ID: 36400089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of influenza vaccination in patients with cardiovascular disease: An overview of systematic reviews.
    Rodrigues BS; Alves M; Duarte GS; Costa J; Pinto FJ; Caldeira D
    Trends Cardiovasc Med; 2021 Jul; 31(5):315-320. PubMed ID: 32535214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta-analysis.
    Modin D; Lassen MCH; Claggett B; Johansen ND; Keshtkar-Jahromi M; Skaarup KG; Nealon J; Udell JA; Vardeny O; Solomon SD; Gislason G; Biering-Sørensen T
    Eur J Heart Fail; 2023 Sep; 25(9):1685-1692. PubMed ID: 37370193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccination in patients with heart failure: A protocol for meta-analysis of randomized controlled trials.
    Fukuta H; Hagiwara H; Kamiya T
    Medicine (Baltimore); 2022 Feb; 101(6):e28844. PubMed ID: 35147132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influenza infection and risk of myocardial infarction: the protective effect of influenza vaccination. One more reason to vaccinate].
    Coutsoumbas GV; Di Pasquale G
    G Ital Cardiol (Rome); 2018 Nov; 19(11):620-627. PubMed ID: 30425391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    Vardeny O; Kim K; Udell JA; Joseph J; Desai AS; Farkouh ME; Hegde SM; Hernandez AF; McGeer A; Talbot HK; Anand I; Bhatt DL; Cannon CP; DeMets D; Gaziano JM; Goodman SG; Nichol K; Tattersall MC; Temte JL; Wittes J; Yancy C; Claggett B; Chen Y; Mao L; Havighurst TC; Cooper LS; Solomon SD;
    JAMA; 2021 Jan; 325(1):39-49. PubMed ID: 33275134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study.
    Wu HH; Chang YY; Kuo SC; Chen YT
    PLoS One; 2019; 14(7):e0219172. PubMed ID: 31260487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccines in immunosuppressed adults with cancer.
    Bitterman R; Eliakim-Raz N; Vinograd I; Zalmanovici Trestioreanu A; Leibovici L; Paul M
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008983. PubMed ID: 29388675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis.
    Jaiswal V; Ang SP; Yaqoob S; Ishak A; Chia JE; Nasir YM; Anjum Z; Alraies MC; Jaiswal A; Biswas M
    Eur J Prev Cardiol; 2022 Oct; 29(14):1881-1892. PubMed ID: 35857821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial.
    Peikert A; Claggett BL; Kim K; Udell JA; Joseph J; Desai AS; Farkouh ME; Hegde SM; Hernandez AF; Bhatt DL; Gaziano JM; Talbot HK; Yancy C; Anand I; Mao L; Cooper LS; Solomon SD; Vardeny O
    Eur J Heart Fail; 2023 Feb; 25(2):299-310. PubMed ID: 36335639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of influenza vaccination on cardiovascular disease.
    Pérez-Rubio A; San Román JA; Eiros Bouza JM
    Med Clin (Barc); 2021 Jul; 157(1):22-32. PubMed ID: 33832764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of influenza, influenza vaccination and cardiovascular risk].
    Jiang Y; Zhang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Feb; 50(2):110-3. PubMed ID: 26926716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influenza vaccination and prognosis for patients with high cardiovascular risk].
    Dmitrieva OA; Mironova OI; Fomin VV
    Ter Arkh; 2021 Sep; 93(9):1100-1105. PubMed ID: 36286871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.
    Vamos EP; Pape UJ; Curcin V; Harris MJ; Valabhji J; Majeed A; Millett C
    CMAJ; 2016 Oct; 188(14):E342-E351. PubMed ID: 27455981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the influenza vaccine at reducing adverse events in patients with heart failure: A systematic review and meta-analysis.
    Gupta C; Sachdeva A; Khamar J; Bu C; Bartoszko J; Loeb M
    Vaccine; 2022 May; 40(25):3433-3443. PubMed ID: 35562195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study.
    Modin D; Claggett B; Køber L; Schou M; Jensen JUS; Solomon SD; Vardeny O; Knop FK; Nielsen SD; Fralick M; Torp-Pedersen C; Gislason G; Biering-Sørensen T
    Diabetes Care; 2020 Sep; 43(9):2226-2233. PubMed ID: 32647052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccines in immunosuppressed adults with cancer.
    Eliakim-Raz N; Vinograd I; Zalmanovici Trestioreanu A; Leibovici L; Paul M
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008983. PubMed ID: 24166741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination.
    Behrouzi B; Udell JA
    Curr Atheroscler Rep; 2021 Oct; 23(12):78. PubMed ID: 34671861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.